Thompson Davis & Co’s Precigen PGEN Stock Holding History

Thompson Davis & Co’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$2K	Buy	+125	New	+$1.86K	﹤0.01%	672
2016 Q1	–	Sell	-1,009	Closed	-$30K	–	1138
2015 Q4	$30K	Buy	1,009 +252	+33%	+$8.49K	0.04%	353
2015 Q3	$24K	Sell	757 -1,639	-68%	-$80K	0.03%	415
2015 Q2	$116K	Buy	2,396 +2,134	+815%	+$89.9K	0.13%	175
2015 Q1	$11K	Buy	262 +131	+100%	+$4.71K	0.01%	697
2014 Q4	$3K	Buy	+131	New	+$2.87K	﹤0.01%	1056
2014 Q2	–	Sell	-131	Closed	-$3K	–	828
2014 Q1	$3K	Buy	+131	New	+$3.63K	0.01%	712

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Thompson Davis & Co's PGEN Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Precigen (PGEN) in Q3 2018: 125 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #672 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in PGEN as recently as Q4 2015.

Thompson Davis & Co first reported a position in PGEN in Q1 2014 and has held it in 7 quarters since. The position peaked at $116K in Q2 2015. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.

Thompson Davis & Co held 125 shares of Precigen worth $2K as of Q3 2018.
Precigen was a new Thompson Davis & Co position in Q3 2018.
Precigen made up ﹤0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #672 holding.
Thompson Davis & Co first reported a position in Precigen in Q1 2014 and has held it in 7 quarters since.
Thompson Davis & Co's Precigen position peaked at $116K in Q2 2015.
170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.